OXFORD BIOCITECH HOLDINGS LIMITED
Get an alert when OXFORD BIOCITECH HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-06 (in 10mo)
Last made up 2026-02-20
Watchouts
Cash
£4M
-44.3% vs 2023
Net assets
-£11M
-135.6% vs 2023
Employees
—
Average over period
Profit before tax
-£42M
-81.6% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
In assessing whether the going concern basis of preparation is appropriate, the directors have identified the above two matters disclosed and have concluded to prepare the financial statements on a going concern basis with material uncertainties in relation to the future operations of the company after the sale of the asset and ability to settle its shareholder loans.
Net assets
2-year trend · vs Real Estate median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £3,635,847 | £2,972,219 | |
| Operating profit | -£22,010,641 | -£39,611,038 | |
| Profit before tax | -£23,280,431 | -£42,276,854 | |
| Net profit | -£23,280,431 | -£42,276,854 | |
| Cash | £6,657,981 | £3,709,456 | |
| Total assets less current liabilities | £88,552,827 | £5,034,906 | |
| Net assets | £30,982,148 | -£11,017,409 | |
| Equity | £30,982,148 | -£11,017,409 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -605.4% | -1332.7% | |
| Net margin | -640.3% | -1422.4% | |
| Return on capital employed | -24.9% | -786.7% | |
| Gearing (liabilities / total assets) | 67.9% | 121.4% | |
| Current ratio | 2.42x | 0.22x | |
| Interest cover | -6.10x | -10.18x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- PricewaterhouseCoopers CI LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“In assessing whether the going concern basis of preparation is appropriate, the directors have identified the above two matters disclosed and have concluded to prepare the financial statements on a going concern basis with material uncertainties in relation to the future operations of the company after the sale of the asset and ability to settle its shareholder loans.”
Group structure
- OXFORD BIOCITECH HOLDINGS LIMITED · parent
- Pills TopCo SCI 100%
- Pills AcquistioCo SCI 65%
- Pills DevCo SCI 65%
Significant events
- “Following year-end, management began actively evaluating proposals received in the context of the conciliation process, in consultation with advisors and the loan provider (CACIB). The process remains ongoing, with all parties aligned on the objective of completing the sale by 31 December 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GEN II CORPORATE SERVICES (JERSEY) LIMITED | Corporate Secretary | 2022-10-27 | — | — |
| DREXLER, Jay | Director | 2024-12-20 | Aug 1984 | Canadian |
| EVERALL, Robin James Ele William | Director | 2022-10-07 | Dec 1980 | English |
| RAWLINSON, Rebecca Mary | Director | 2026-04-21 | May 1988 | English |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CRESTBRIDGE UK LIMITED | Corporate Secretary | 2022-02-21 | 2022-10-27 |
| CHEN, Joy | Director | 2025-09-15 | 2026-04-21 |
| HODGETTS, Ann Mary | Director | 2022-02-21 | 2023-05-22 |
| LAMBERT, Alison Jane, Ms. | Director | 2022-02-21 | 2022-10-01 |
| RAWLINSON, Rebecca Mary | Director | 2024-02-01 | 2025-04-24 |
| SHAPIRO, Abigail Jane | Director | 2023-05-22 | 2024-12-20 |
| SHEARER, Henry Charles | Director | 2022-02-21 | 2022-07-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Life Sciences (Uk) Holdings Ii Limited | Corporate entity | ownership-of-shares-75-to-100-percent-as-firm, voting-rights-75-to-100-percent-as-firm, right-to-appoint-and-remove-directors-as-firm | 2022-02-21 | Active |
Filing timeline
Last 20 of 40 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-23 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-23 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-19 | SH01 | capital | Capital allotment shares | |
| 2026-03-02 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-02-06 | SH01 | capital | Capital allotment shares | |
| 2025-12-05 | AA | accounts | Accounts with accounts type group | |
| 2025-09-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-08-01 | SH01 | capital | Capital allotment shares | |
| 2025-05-12 | SH01 | capital | Capital allotment shares | |
| 2025-04-24 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-01-03 | RP04SH01 | capital | Second filing capital allotment shares | |
| 2024-12-30 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-27 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-06 | SH01 | capital | Capital allotment shares | |
| 2024-10-21 | AA | accounts | Accounts with accounts type total exemption full | |
| 2024-08-08 | SH01 | capital | Capital allotment shares | |
| 2024-04-19 | CH04 | officers | Change corporate secretary company with change date | |
| 2024-02-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-02-28 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 7
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-18.3%
£3,635,847 £2,972,219
-
Cash
-44.3%
£6,657,981 £3,709,456
-
Net assets
-135.6%
£30,982,148 -£11,017,409
-
Employees
—
Not reported
-
Operating profit
-80%
-£22,010,641 -£39,611,038
-
Profit before tax
-81.6%
-£23,280,431 -£42,276,854
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers